4.8 Article

Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression

Journal

NATURE GENETICS
Volume 44, Issue 11, Pages 1191-1198

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ng.2416

Keywords

-

Funding

  1. US National Cancer Institute (NCI) [2P30CA023108-32]
  2. American Cancer Society (ACS) [1RG-82-003-27]
  3. US National Institutes of Health (NIH) [R01LM009012, R01CA155004]
  4. Princess Margaret Hospital Foundation
  5. Div Of Biological Infrastructure
  6. Direct For Biological Sciences [0923008] Funding Source: National Science Foundation

Ask authors/readers for more resources

Genome-wide association studies (GWAS) have identified thousands of SNPs that are associated with human traits and diseases. But, because the vast majority of these SNPs are located in non-coding regions of the genome, the mechanisms by which they promote disease risk have remained elusive. Employing a new methodology that combines cistromics, epigenomics and genotype imputation, we annotate the non-coding regions of the genome in breast cancer cells and systematically identify the functional nature of SNPs associated with breast cancer risk. Our results show that breast cancer risk-associated SNPs are enriched in the cistromes of FOXA1 and ESR1 and the epigenome of histone H3 lysine 4 monomethylation (H3K4me1) in a cancer- and cell type-specific manner. Furthermore, the majority of the risk-associated SNPs modulate the affinity of chromatin for FOXA1 at distal regulatory elements, thereby resulting in allele-specific gene expression, which is exemplified by the effect of the rs4784227 SNP on the TOX3 gene within the 16q12.1 risk locus.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available